References
- Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011). Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. The Cochrane Database of Systematic Reviews, 5(10), CD004147. https://doi.org/10.1002/14651858.CD004147.pub4
- Ambekar, A., Kumar, R., Rao, R., Agrawal, A., Kumar, M., & Mishra, A. K. (2015). Punjab opioid dependence survey. Retrieved from http://pbhealth.gov.in/scan0003%20(2).pdf
- Ambekar, A., Rao, R., Mishra, A. K., & Agrawal, A. (2015). Type of opioids injected: Does it matter? A multicentric cross-sectional study of people who inject drugs: Types of opioid injected: Does it matter? Drug and Alcohol Review, 34(1), 97–104. https://doi.org/10.1111/dar.2015.34.issue-1
- Armstrong, G., Kermode, M., Sharma, C., Langkham, B., & Crofts, N. (2010). Opioid substitution therapy in manipur and nagaland, north-east india: Operational research in action. Harm Reduction Journal, 7, 29. https://doi.org/10.1186/1477-7517-7-29
- Avasthi, A., Basu, D., Subodh, B. N., Gupta, P. K., Sidhu, B. S., Gargi, P. D., Sharma, A., Ghosh, A., & Rani, P. (2018). Epidemiology of substance use and dependence in the state of Punjab, India: Results of a household survey on a statewide representative sample. Asian Journal of Psychiatry, 33, 18–29. https://doi.org/10.1016/j.ajp.2018.02.017
- Basu, D., Kumar, V., Sharma, A. K., Barnwal, P. K., & Mattoo, S. K. (2013). Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: Comparison with non-injecting drug users. Asian Journal of Psychiatry, 6(1), 52–55. https://doi.org/10.1016/j.ajp.2012.08.008
- Basu, D., Sharma, A., Gupta, S., Nebhinani, N., & Kumar, V. (2015). Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in northern India. Indian Journal of Medical Research, 142(3), 311. https://doi.org/10.4103/0971-5916.166596
- Beardsley, K., Wish, E. D., Fitzelle, D. B., O’Grady, K., & Arria, A. M. (2003). Distance traveled to outpatient drug treatment and client retention. Journal of Substance Abuse Treatment, 25(4), 279–285. https://doi.org/10.1016/S0740-5472(03)00188-0
- Bojko, M. J., Mazhnaya, A., Marcus, R., Makarenko, I., Islam, Z., Filippovych, S., Dvoriak, S., & Altice, F. L. (2016, July). The future of opioid agonist therapies in Ukraine: A qualitative assessment of multilevel barriers and ways forward to promote retention in treatment. Journal of Substance Abuse Treatment, 66, 37–47. https://doi.org/10.1016/j.jsat.2016.03.003
- Bukten, A., Skurtveit, S., Waal, H., & Clausen, T. (2014). Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study. Addictive Behaviors, 39(10), 1504–1509. https://doi.org/10.1016/j.addbeh.2014.05.007
- Cao, X., Wu, Z., Rou, K., Li, L., Lin, C., Wang, C., & National Working Group on Methadone Maintenance Treatment Program. (2014, December 1). Retention and its predictors among methadone maintenance treatment clients in China: A six-year cohort study. Drug and Alcohol Dependence, 145, 87–93. https://doi.org/10.1016/j.drugalcdep.2014.09.776
- Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., Fry-Smith, A., Day, E., Lintzeris, N., Roberts, T., Burls, A., & Taylor, R. S. (2007). Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technology Assessment (Winchester, England), 11(9), 1–171, iii–iv. https://doi.org/10.3310/hta11090
- Coviello, D. M., Zanis, D. A., Wesnoski, S. A., & Domis, S. W. (2009). An integrated drug counseling and employment intervention for methadone clients. Journal of Psychoactive Drugs, 41(2), 189–197. https://doi.org/10.1080/02791072.2009.10399912
- Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., & Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet Global Health, 5(12), e1192–e1207. https://doi.org/10.1016/S2214-109X(17)30375-3
- Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., Hall, W. D., Freedman, G., Burstein, R., Johns, N., Engell, R.E., & Freedman, A. (2013). Global burden of disease attributable to illicit drug use and dependence: Findings from the global burden of disease study 2010. The Lancet, 382(9904), 1564–1574. https://doi.org/10.1016/S0140-6736(13)61530-5
- Dennis, B. B., Roshanov, P. S., Naji, L., Bawor, M., Paul, J., Plater, C., Pare, G., Worster, A., Varenbut, M., Daiter, J., Marsh, D. C., Desai, D., Samaan, Z., & Thabane, L. (2015). Opioid substitution and antagonist therapy trials exclude the common addiction patient: A systematic review and analysis of eligibility criteria. Trials, 16(475). https://doi.org/10.1186/s13063-015-0942-4
- Dhawan, A., Jain, R., & Chopra, A. (2010). Opioid substitution - buprenorphine in India. UNODC, Regional Office for South Asia.
- Dhawan, A., Rao, R., Ambekar, A., Chopra, A., Jain, R., Yadav, D., & Ray, R. (2014). Methadone maintenance treatment in India: A feasibility and effectiveness report. UNODC, Regional Office for South Asia & NDDTC, AIIMS. Retrieved from https://www.unodc.org/documents/southasia/publications/research-studies/MMT_REPORT_final.pdf
- Dugosh, K., Abraham, A., Seymour, B., McLoyd, K., Chalk, M., & Festinger, D. (2016). A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. Journal of Addiction Medicine, 10(2), 93–103. https://doi.org/10.1097/ADM.0000000000000193
- Feelemyer, J., Des Jarlais, D., Arasteh, K., Abdul-Quader, A. S., & Hagan, H. (2014). Retention of participants in medication-assisted programs in low- and middle-income countries: An international systematic review. Addiction (Abingdon, England), 109(1), 20–32. https://doi.org/10.1111/add.2014.109.issue-1
- Global State of Harm Reduction 2016. (2017, January 19). Retrieved from https://www.hri.global/contents/1739
- Jiang, H., Han, Y., Du, J., Wu, F., Zhang, R., Zhang, H., Wang, J., Zhou, Z., Hser, Y. I., & Zhao, M. (2014). Factors associated with one year retention to methadone maintenance treatment program among patients with heroin dependence in China. Substance Abuse Treatment, Prevention, and Policy, 9, 11. https://doi.org/10.1186/1747-597X-9-11
- Kennedy-Martin, T., Curtis, S., Faries, D., Robinson, S., & Johnston, J. (2015). A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials, 16, 495. https://doi.org/10.1186/s13063-015-1023-4
- Kermode, M., Armstrong, G., & Waribam, S. (2011). Long-term follow up of clients from a community-based opioid substitution therapy programme in Manipur. The Indian Journal of Medical Research, 134(5), 732–734. https://doi.org/10.4103/0971-5916.91014
- King, V. L., Stoller, K. B., Hayes, M., Umbricht, A., Currens, M., Kidorf, M. S., Carter, J. A., Schwartz, R., & Brooner, R. K. (2002). A multicenter randomized evaluation of methadone medical maintenance. Drug and Alcohol Dependence, 65(2), 137–148. https://doi.org/10.1016/S0376-8716(01)00155-7
- Lawrinson, P., Ali, R., Buavirat, A., Chiamwongpaet, S., Dvoryak, S., Habrat, B., Jie, S., Mardiati, R., Mokri, A., Moskalewicz, J., Newcombe, D., Poznyak, V., Subata, E., Uchtenhagen, A., Utami, D. S., Vial, R., & Zhao, C. (2008). Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction (Abingdon, England), 103(9), 1484–1492. https://doi.org/10.1111/add.2008.103.issue-9
- Mahajan, P., Singh, M., Garg, A., Dass Garg, P., & Singh, G. (2016). Prevalence of hepatitis-C viral infection among opioid dependent injectable drug users: A study conducted at Swami Vivekananda drug de-addiction and treatment centre, amritsar. Dual Diagnosis Open Access, 1(2). https://doi.org/10.21767/2472-5048
- Matson, S. C., Hobson, G., Abdel-Rasoul, M., & Bonny, A. E. (2014). A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic. Journal of Addiction Medicine, 8(3), 176–182. https://doi.org/10.1097/ADM.0000000000000035
- Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. The Cochrane Database of Systematic Reviews, (3), CD002209. https://doi.org/10.1002/14651858.CD002209.pub2
- Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. The Cochrane Database of Systematic Reviews, (2), CD002207. https://doi.org/10.1002/14651858.CD002207.pub4
- Mehta, S. H., Vogt, S. L., Srikrishnan, A. K., Vasudevan, C. K., Murugavel, K. G., Saravanan, S., Anand, S., Kumar, M.S., Ray, S.C., Celentano, D.D., & Solomon, S. S. (2010). Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India. The Indian Journal of Medical Research, 132(6), 706–714.
- Mullen, L., Barry, J., Long, J., Keenan, E., Mulholland, D., Grogan, L., & Delargy, I. (2012). A national study of the retention of Irish opiate users in methadone substitution treatment. The American Journal of Drug and Alcohol Abuse, 38(6), 551–558. https://doi.org/10.3109/00952990.2012.694516
- Öhlin, L., Fridell, M., & Nyhlén, A. (2015). Buprenorphine maintenance program with contracted work/education and low tolerance for non-prescribed drug use: A cohort study of outcome for women and men after seven years. BMC Psychiatry, 15, 56. https://doi.org/10.1186/s12888-015-0415-z
- Peles, E., Schreiber, S., & Adelson, M. (2006). Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug and Alcohol Dependence, 82(3), 211–217. https://doi.org/10.1016/j.drugalcdep.2005.09.004
- Rao, R. (2017). The journey of opioid substitution therapy in India: Achievements and challenges. Indian Journal of Psychiatry, 59(1), 39–45. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_37_17
- Ray, R., Justice, I. M. of S., Empowerment, Drugs, U. N. O. on, & Asia, C. R. O. for S. (2004). The extent, pattern and trends of drug abuse in India: National survey. Ministry of Social Justice and Empowerment, Government of India & United Nations Office on Drugs and Crime, Regional Office for South Asia. https://books.google.co.in/books?id=pB5iGwAACAAJ
- Rosenblum, A., Cleland, C. M., Fong, C., Kayman, D. J., Tempalski, B., & Parrino, M. (2011). Distance traveled and cross-state commuting to opioid treatment programs in the United States. Journal of Environmental and Public Health, 2011, 1–10. https://doi.org/10.1155/2011/948789
- Rothwell, P. M. (2005). External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet (London, England), 365(9453), 82–93. https://doi.org/10.1016/S0140-6736(04)17670-8
- UNODC. (2017). World drug report 2017. https://www.unodc.org/wdr2017/field/WDR17_Fact_sheet.pdf
- Wei, X., Wang, L., Wang, X., Li, J., Li, H., & Jia, W. (2013). A study of 6-year retention in methadone maintenance treatment among opioid-dependent patients in Xi’an. Journal of Addiction Medicine, 7(5), 342–348. https://doi.org/10.1097/ADM.0b013e31829da05b
- World Health Organization, United Nations Office on Drugs and Crime, & Joint United Nations Programme on HIV/AIDS. (2004). Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: WHO/UNODC/UNAIDS position paper. WHO.